Wordt geladen...
紫杉醇脂质体联合顺铂方案一线治疗晚期非小细胞肺癌的临床随机对照研究
BACKGROUND AND OBJECTIVE: Paclitaxel plus cisplatin (TP) is used as the standard regimen for patients with advanced non-small cell lung cancer (NSCLC). In this study, we compared the response rate (RR), overall survival (OS), and toxicity of the combined chemotherapy regimen of liposomal paclitaxel...
Bewaard in:
| Gepubliceerd in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
中国肺癌杂志编辑部
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999984/ https://ncbi.nlm.nih.gov/pubmed/22510505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2012.04.03 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|